PuSH - Publication Server of Helmholtz Zentrum München: Tumor lactic acidosis: Protecting tumor by inhibiting cytotoxic activity through motility arrest and bioenergetic silencing.

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

Fischbeck, A. ; Ruehland, S.* ; Ettinger, A. ; Paetzold, K. ; Masouris, I. ; Nößner, E. ; Mendler, A.N.

Tumor lactic acidosis: Protecting tumor by inhibiting cytotoxic activity through motility arrest and bioenergetic silencing.

Front. Oncol. 10:589434 (2020)

Postprint

Research data

DOI

PMC

	Open Access Gold

Abstract
Metrics
Extra information

Adoptive T cell therapy (ACT) is highly effective in the treatment of hematologic malignancies, but shows limited success in solid tumors. Inactivation of T cells in the tumor milieu is a major hurdle to a wider application of ACT. Cytotoxicity is the most relevant activity for tumor eradication. Here, we document that cytotoxic T cells (CTL) in lactic acidosis exhibited strongly reduced tumor cell killing, which could be compensated partly by increasing the CTL to tumor cell ratio. Lactic acid intervened at multiple steps of the killing process. Lactic acid repressed the number of CTL that performed lytic granule exocytosis (degranulation) in tumor cell co-culture, and, additionally impaired the quality of the response, as judged by the reduced intensity of degranulation and lower secretion of cytotoxins (perforin, granzyme B, granzyme A). CTL in lactic acid switched to a low bioenergetic profile with an inability to metabolize glucose efficiently. They responded to anti-CD3 stimulation poorly with less extracellular acidification rate (ECAR). This might explain their repressed granule exocytosis activity. Using live cell imaging, we show that CTL in lactic acid have reduced motility, resulting in lower field coverage. Many CTL in lactic acidosis did not make contact with tumor cells; however, those which made contact, adhered to the tumor cell much longer than a CTL in normal medium. Reduced motility together with prolonged contact duration hinders serial killing, a defining feature of killing potency, but also locally confines cytotoxic activity, which helps to reduce the risk of collateral organ damage. These activities define lactic acid as a major signaling molecule able to orchestrate the spatial distribution of CTL inside inflamed tissue, such as cancer, as well as moderating their functional response. Lactic acid intervention and strategies to improve T cell metabolic fitness hold promise to improve the clinical efficacy of T cell–based cancer immunotherapy.

Altmetric

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Scientific Article

Corresponding Author

Keywords Cytolytic T Cells ; Degranulation ; Glycolytic State ; Immunotherapy ; Killing Potency ; Serial Killing ; T Cell Metabolism; Cd8(+) T-cells; Immune Suppression; Extracellular Ph; Cancer; Lactate; Therapy; Acidity; Assay; Microenvironment; Immunotherapy

ISSN (print) / ISBN 2234-943X

e-ISSN 2234-943X

Journal Frontiers in Oncology

Quellenangaben Volume: 10, Article Number: 589434

Publisher Frontiers

Publishing Place Avenue Du Tribunal Federal 34, Lausanne, Ch-1015, Switzerland

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) CF Immunoanalytics (IMA)
Institute of Epigenetics and Stem Cells (IES)
Institute of Molecular Immunology (IMI)

Grants Erich & Gertrud Roggenbuck Stiftung
Deutsche Krebshilfe